23 May 2013
Keywords: ph, iii, xarelto, data, presented, ash, bayer
Article | 19 November 2007
Bayer HealthCare, part of Germany's Bayer Group, has announced plans to present data from a Phase III trial of its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
19 November 2007
22 May 2013
© 2013 thepharmaletter.com